Skip to content

Cardiovascular Risk in Toledo Population

RIesgo CARdiovascular y Eventos Cardiovasculares en la población General Del área Sanitaria de TOledo

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03294369
Acronym
RICARTO
Enrollment
3125
Registered
2017-09-27
Start date
2011-04-01
Completion date
2020-12-31
Last updated
2020-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Cardiovascular Risk Factor

Keywords

Hypertension, Diabetes, Dyslipidemia, Smoking, Cardiovascular, Toledo

Brief summary

This epidemiological and observational study is aimed to assess cardiovascular risk (CVR) by investigating the prevalence of CVR factors (CVRF), target organ damage (TOD) and cardiovascular disease (CVD) in general population of the sanitary area of Toledo.

Detailed description

Epidemiological and observational study that is analyzing a sample from the general population aged 18 years or older, randomly selected from a database of sanitary cards stratified by age and gender. Clinical history, physical examination and complementary tests are being performed. Total blood and serum samples are being frozen (-85ºC) for future genetic studies. The biobank is currently being registered at the Virgen de la Salud hospital of Toledo. CVR is assessed by SCORE scale calibrated for Spanish population and the Framingham Heart Study scale. Patients will be periodically visited, with a minimum follow-up of 5 years. Standard statistical analysis will be performed.

Interventions

OTHERObservational

This is an observational study. No specific diagnostic or therapeutic procedure will be performed due to the study.

Sponsors

Castile-La Mancha Government (Socio-Sanitary Foundation of Castile-La Mancha)
CollaboratorUNKNOWN
SEMERGEN (Spanish Society of Primary Care Physicians)
CollaboratorUNKNOWN
Castilla-La Mancha Health Service
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subjects aged 18 years or older, randomly selected from a database of health cards stratified by age and gender

Exclusion criteria

* Individulas aged under 18 years. * Subjects who do not sign the informed consent. * Subjects that due to different conditions (physical, mental or social) is expected that do not complete the expected follow-up.

Design outcomes

Primary

MeasureTime frameDescription
Assess cardiovascular risk of the study populationDecember 2020Cardiovascular risk will be determined according to SCORE scale calibrated for Spanish population and the Framingham Heart Study scale.
Prevalence of cardiovascular risk factorsDecember 2020To assess the prevalence of cardiovascular risk factors
Prevalence of cardiovascular diseaseDecember 2020To assess the prevalence of cardiovascular disease

Countries

Spain

Contacts

Primary ContactGustavo C Rodriguez-Roca, MD, PhD
gcrodriguezroca@gmail.com608293478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026